EUCTR2013-005006-66-GB进行中（未招募）1 期
A 2-arm, randomised, single - (Investigator) blind, controlled, parallel design study in common cold sufferers experiencing nasal congestion to assess the speed of action of Vicks® VapoRub® (VVR) - Speed
Procter and Gamble0 个研究点目标入组 50 人开始时间: 2013年12月16日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •a) be generally healthy by report and review of medication/medical history;
- •b) are at least 18 years of age;
- •c) report that they are suffering from a self-diagnosed common cold of no more than 5 days’ duration;
- •d) report that they are suffering from at least mild nasal congestion (score of at least 1 on the 4-point ordinal scale);
- •e) are willing and able to refrain from eating, drinking, smoking, and putting anything into the mouth for a period of approximately 1 hour;
- •f) are willing and able to stay alert and awake for a period of approximately 1 hour;
- •g) if female and of child-bearing potential, have practiced abstinence or used an effective form of birth control (eg, intrauterine device, oral contraceptives, contraceptive implants or injections, diaphragm with spermicide, cervical cap, or consort use of condom) for at least 3 months before being enrolled in the study; and
- •h) have read, understood, signed, and received a copy of the Informed Consent prior to initiation of the study procedures.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •a) have a clinically significant nasal abnormality (eg, deviated septum, ulcer, septal perforation, or polyp) discovered during the nasal examination at Screening;
- •b) have history of clinically relevant anosmia;
- •c) have a history of allergy or hypersensitivity to the following ingredients: menthol, eucalyptus, turpentine, camphor, thymol, cedarwood;
- •d) have a history of airway disease or pronounced hypersensitivity of the airways/asthma;
- •e) have an oral body temperature > 100.5°F (38.1°C);
- •f) have used nasal decongestants (including but not limited to phenylephrine, oxymetazoline, or pseudoephedrine) in the past 24 hours;
- •g) have used inhaled, topical, or oral nedocromil or cromolyn sodium, tricyclic antidepressant medications, or MAO inhibitors for 14 days prior to screening;
- •h) have a history of alcohol or drug abuse within the past 2 years;
- •i) are currently enrolled in another clinical trial, or have received any other investigational drug within the past 30 days;
- •j) if female and of child-bearing potential, have a positive urine pregnancy test at screening or report they are pregnant, trying to become pregnant, or lactating;
- •k) have a history of malignancy within the past 2 years, other than treated basal cell carcinoma;
- •l) have a condition (eg, history of clinically significant pulmonary, autoimmune, psychiatric, neurologic, hematologic/oncologic, metabolic, endocrine, gastrointestinal, hepatic or renal disease) or are taking a medication, wearing devices, utilizing medicated skin ointments or creams and aromatic body creams or solutions that the Investigator believes would interfere with the evaluation of the study, pose a safety risk, or confound the interpretation of the study results.
研究者
相似试验
进行中（未招募）
1 期
A Trial to assess the effects of Vicks® VapoRub® (VVR) on sleep qualitySleep disruption due to cough and nasal congestion during a cold.MedDRA version: 14.1 Level: LLT Classification code 10000938 Term: Acute nasopharyngitis (common cold) System Organ Class: 100000004862MedDRA version: 14.1 Level: LLT Classification code 10009851 Term: Cold System Organ Class: 100000004862EUCTR2013-004524-11-GBProctor and Gamble Technical Centres Ltd100
撤回
4 期
A randomized, two-arm, prospective, subject blind study to assess the safety and efficacy of InSpace* device in comparison to full thickness massive rotator cuff repair in subjects scheduled for a repair surgery.massive rotator cuff tearsrupture of the muscles around the shoulder10028302NL-OMON40993OrthoSpace LTD.40
已完成
2 期
Clinical study to evaluate and compare the immunogenicity and safety of Tetanus vaccine of Cadila Healthcare Ltd. vs Tetanus vaccine of Serum Institute of India Ltd. in healthy subjects and subjects with clean minor woundsCTRI/2015/05/005740Cadila Healthcare Ltd283
招募中
2 期
Clinical study to compare the immune response and safety of trivalent flu vaccine manufactured by Cadila Healthcare Ltd. with a trivalent flu vaccine marketed in India in healthy adultsCTRI/2015/09/006208Cadila Healthcare Ltd348
招募中
2 期
Clinical study to compare the immune response and safety of tetravalent flu vaccine manufactured by Cadila Healthcare Ltd. with a trivalent flu vaccine marketed in India in healthy adultsCTRI/2015/09/006209Cadila Healthcare Ltd348